Acute Lymphoblastic Leukaemia in the Elderly

References

• Gorst D. W., Johnson K. W. Survival in adult leukaemia. Clin. Lab. Haematol. 1992; 14: 99–108
   PubMedGoogle Scholar
• Cartwright R. A. Epidemiology. Leukaemia, J. A. Whittaker. Blackwell, Oxford 1992
   Google Scholar
• OPCS. Population projections by the government actuary. United Kingdom. Mid-1987 based projections. HMSO. 1991
   Google Scholar
• Taylor P. R. A., Reid M. M., Bown N., Hamilton P. J., Proctor S. J., on behalf of the Northern Region Haematology Group. Acute lymphoblastic leukemia in patients aged sixty years and over: a population based study of incidence and outcome. Blood 1992; 80: 1813–1817
   PubMed Web of Science ®Google Scholar
• Bailey C. C. The acute lymphoblastic leukaemias. Leukaemia, J. A. Whittaker. Blackwell Scientific Publications, Oxford 1992; 395–415
   Google Scholar
• Ross J. R. Y., Gilbert M. J. Leukaemia survival in an unselected cohort of patients. The Oxford Region leukaemia register. Br. J. Haematol. 1993; 84(Suppl. 1)37, Abstract
   Google Scholar
• Neilan B. A. Effect of age on prognosis. Cancer in the elderly: basic science and clinical aspects, D. A. Lipschiltz. Annals of Internal Medicine. 1985; 225–226
   Google Scholar
• Seeker-Walker L. M., Craig J. M., Hawkins J. M., Hoffbrand A. V. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia 1991; 5: 196–199
   PubMed Web of Science ®Google Scholar
• Maurer J., Janssen J. W. G., Thiel E., van Deideren J., Ludwig W-D., Aydemir U., Heinze B., Fonatsch C., Har-Bott J, Reiter A., Riehm H., Hoelzer D., Bartram C. R. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055–1058
   PubMed Web of Science ®Google Scholar
• Seeker-Walker L. M., Craig J. M. Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukaemia: a review. Leukemia 1993; 7: 147–151
   PubMed Web of Science ®Google Scholar
• Berger R., Chen S. J., Chen Z. Philadelphia-positive acute leukaemia. Cytogenetic and molecular aspects. Cancer Genet. Cytogenet. 1990; 44: 143–152
   PubMed Web of Science ®Google Scholar
• Walters R., Kantarjian H. M., Keating M. J., et al. The importance of cytogenetic studies in adult acute lymphocytic leukemia. Am. J. Med. 1990; 89: 579–584
   PubMed Web of Science ®Google Scholar
• Delannoy A., Ferrant A., Bosly A., Chatelain C., Doyen C., Martiat P., Michaux J. L., Sokol G. Acute lymphoblastic leukaemia in the elderly. Eur. J. Haematol. 1990; 45: 90–93
   PubMed Web of Science ®Google Scholar
• Barnett M. J., Greaves M. F., Amess J. A. L., Gregory W. M., Rohatiner A. Z. S., Dhaliwal H. S., Slevin M. L., Biruls R., Malpas J. S., Lister T. A. Treatment of lymphoblastic leukaemia in adults. Br. J. Haematol. 1986; 64: 455–468
   PubMed Web of Science ®Google Scholar
• Foa R., Baldini L., Cattoretti G., Foa P., Gobbi M., Lau-Ria F, Madon E., Masera G., Miniero R., Paolucci P., Perona G., Pizzolo G., Saitta M., Gavosto F. Multi phenotypic characterization of adult and childhood acute lymphoblastic leukaemia: an Italian multicentre study. Br. J. Haematol. 1985; 61: 251–259
   PubMed Web of Science ®Google Scholar
• Smedmyr B., Simonsson B., Sundstrom C., For the Swedis-Ghroup all. Acute lymphoblastic leukaemia in adults in Sweden 1977–84: a retrospective analysis. Eur. J. Haematol. 1989; 43: 167–172
   PubMed Web of Science ®Google Scholar
• Mauer A. M. Adult and childhood acute lymphocytic leukemia: are they different diseases?. Am. J. Haematol. 1993; 42: 127–131
   PubMed Web of Science ®Google Scholar
• Court Brown W. M., Doll R. Leukaemia in childhood and young adult life. Trends in mortality in relation to aetiology. Br. Med. J. 1961; 981: 988
   Google Scholar
• Greaves M. F., Colman S. M., Beard M. E. J., Bradstock K., Cabrera M. E., Chen P-M., Jacobs P., Cam-Po-Tang P. R. L., MacDougall L. G., Williams C. K. O., Alexander F. E. Geographical distribution of acute lymphoblastic leukaemia subtypes: second report of the Collaborative Group Study. Leukemia 1993; 7: 27–34
   PubMed Web of Science ®Google Scholar
• Stiller C. A., McKinney P. A., Bunch K. J., Bailey C. C., Lewis I. J. Childhood cancer and ethnic group in Britain: a United Kingdom Children's Cancer Study Group (UKCCSG) Study. Br. J. Cancer 1991; 64: 543–548
   PubMed Web of Science ®Google Scholar
• Parkin D. M., Stiller C. A., Draper G. J., Bieber C. A. The international incidence of childhood cancer. Int. J. Cancer 1988; 42: 511–520
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Alexander F. An infectious etiology for common acute lymphoblastic leukaemia in childhood?. Leukemia 1993; 17: 349–360
   Google Scholar
• Ellison R. R., Mick R., Cuttner J., Schiffer C. A., Silver R. T., Henderson E. S., Woliver T., Royston I., Davey F. R., Glicksman A. S., Bloomfield C. D., Holland J. F. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by cancer and leukemia group B. J. Clin. Oncol. 1991; 9: 2002–2015
   PubMed Web of Science ®Google Scholar
• Finnish Leukaemiaroup G. Long-term survival in acute lymphoblastic leukaemia in adults: a prospective study of 51 patients. Eur. J. Haematol. 1992; 48: 75–82
   PubMed Web of Science ®Google Scholar
• Jasmin C. Leukemic stem cells and the curability of leukemias (Editorial). Leukemia Res. 1988; 12: 703–705
   PubMed Web of Science ®Google Scholar
• Gottlieb A. J., Weinberg V., Ellison R. R., et al. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukaemia: a prospective randomised trial by Cancer and Leukaemia Group B. Blood 1984; 64: 267–274
   PubMed Web of Science ®Google Scholar
• Maung Z. T., Hall A. G., Reid M. M., Proctor S. J. In-vitro drug sensitivity testing in acute lymphoblastic leukaemia using the tetrazolium-based MTT assay. Br. J. Haematol 1993; 84(Suppl. 1)29, Abstract
   Google Scholar
• Cuttner J., Mick R., Budman D. R., Mayer R. J., Lee E. J., Henderson E. S., Weiss R. B., Paciucci P. A., So-Bol R, Davey F., Bloomfield C., Schiffer C. Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB study. Leukemia 1991; 5: 425–431
   PubMed Web of Science ®Google Scholar
• Stewart K., Keating A., Sutton D., Scott J. G., Fran-Combe W, Carter W. H., Baker M. A. Adult acute lymphoblastic leukaemia: the value of therapy intensification. Leukemia and Lymphoma 1991; 4: 103–110
   PubMed Web of Science ®Google Scholar
• Carey P., Proctor S. J., Taylor P., Hamilton P. J., on behalf of the Northern Regional Bone Marrow Transplant Group. Autologous bone marrow transplantation for high grade lymphoid malignancy using Melphalan/irradiation conditioning without marrow purging or cryopreservation. Blood 1991; 77: 1593–1598
   PubMed Web of Science ®Google Scholar
• Prentice H. G., Lee N., Blocklock H., et al. Therapeutic selectivity of and prediction of response to 2′-deox-ycoformycin in acute leukaemia. Leukemia 1981; 2: 1250–1254
   Google Scholar
• Poplack D. G., Sallan S. E., Rivera G., et al. Phase I study of 2′-deoxycoformycin in acute lymphoblastic leukaemia. Cancer Res. 1981; 41: 3343–3346
   PubMed Web of Science ®Google Scholar
• Kloke O., Niederle N., Qiu J. Y., Wandl U., Moritz T., Nagel-Hiemke M., Hawig I., Opalka B. Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia. Br. J. Haematol. 1993; 83: 399–403
   PubMed Web of Science ®Google Scholar
• Talpaz M., Kantarijan M. M., McCredie B., et al. Clinical investigation of human alpha-interferon in chronic myelogenous leukaemia. Blood 1987; 69: 1280–1288
   PubMed Web of Science ®Google Scholar
• Haas O. A. Treatment of Ph-positive acute lymphoblastic leukemia with a-interferon. Leukemia 1988; 2: 555
   PubMed Web of Science ®Google Scholar
• Ohyashiki K., Ohyashiki J. H., Tauchi T., Fujieda H., Hojo H., Ohtaka M., Saito M., Nakazawa S., Toy-Ama K. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a pilot study which raises important questions. Leukemia 1991; 5: 611–614
   PubMed Web of Science ®Google Scholar
• Ochs J., Brecher M. L., Mahoney D., Vega R., Pollock B. H., Buchanan G. R., Whitehead V. M., Ravindranath Y., Freeman A. Recombinant interferon alfa given before and in combination with standard chemotherapy in children with acute lymphoblastic leukaemia in first marrow relapse: a pediatric oncology group pilot study. J. Clin. Oncol. 1991; 9: 777–782
   PubMed Web of Science ®Google Scholar
• Archimbaud E., Thomas X., Campos L., Magaud J.-P., Fiere D., Doné J.-F. Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-acti-vated killer cells. Leukemia 1991; 5: 967–971
   PubMed Web of Science ®Google Scholar
• Dickinson A. M., Lennard A. L., Cartner R., Proctor S. J. Interleukin-2 induction of lymphokine-activated killer activity in the peripheral blood of an acute lymphoblastic leukaemia patient—case study. Leukemia 1992; 6: 957–960
   PubMed Web of Science ®Google Scholar
• Fentiman I., Tirelli U., Monfardini S., et al. Why is cancer so badly treated in the elderly?. Leukemia 1990; 335: 1020–1022
   Google Scholar